Related by context. All words. (Click for frequent words.) 68 therapeutic monoclonal antibodies 67 mAbs 66 humanized monoclonal antibodies 66 recombinant antibodies 66 polyclonal antibodies 66 monoclonal antibodies 66 novel peptide 65 humanized antibody 65 human monoclonal antibody 64 monoclonal antibodies mAbs 64 therapeutic monoclonal antibody 64 prophylactic vaccines 64 IMA# 64 human antibody therapeutics 64 TLR9 agonists 64 NEUGENE 64 transfection reagents 63 MAbs 63 anticancer therapeutics 63 nanomedicines 62 dAbs 62 monoclonal antibody therapeutics 62 monoclonal antibody mAb 62 VitiGam 62 recombinant polyclonal antibodies 62 RNAi therapeutic targeting 62 molecular abnormalities 62 cellular immunotherapy 62 IgG1 antibody 62 novel antibody therapeutics 62 immunomodulators 62 miRNA biomarkers 61 A3 adenosine receptor 61 antiviral compounds 61 PEGylated 61 glycosylated 61 monoclonal 61 biomarker identification 61 Zalypsis 61 kinase profiling 61 HQK 61 mertansine 61 immunotherapeutics 61 potent cytotoxic 61 Monoclonal antibody 61 kidney urologic 61 anti idiotype 61 DNA methylation biomarkers 61 Anticalins R 61 histone deacetylase HDAC 61 neovascular diseases 61 radiotherapeutic 61 CYT# potent vascular disrupting 61 Onconase 61 OncoVex 61 predictive biomarkers 61 molecularly targeted 61 NovaBay Aganocide compounds 61 molecular biomarkers 61 targeted radiotherapeutic 61 therapeutic antibodies 61 Nanobody 60 Hemopurifier TM 60 Nanobodies ® 60 BCR ABL inhibitors 60 stem cells CSCs 60 tubulin inhibitor 60 anti CD# antibodies 60 taxane derivative 60 carbohydrate polymers 60 UsiRNAs 60 protein kinase inhibitors 60 novel immunotherapies 60 polyclonal antibody 60 targeted antifolate 60 methylation markers 60 molecular imaging radiopharmaceuticals 60 peptide antigens 60 Nanobody ® 60 siRNA sequences 60 xTAG RVP 60 rxRNA TM compounds 60 EGFR HER 60 NPC 1C 60 siRNA therapeutic 60 proteasome inhibitors 60 tumor antigen 60 proteasome inhibitor 60 Curaxin 60 diagnostic biomarker 60 recombinant polyclonal antibody 60 tumor antigens 60 GVAX ® 60 immunotherapies 60 monoclonal antibody 60 molecular diagnostic assays 60 radezolid 60 Affibody ® molecules 60 polyclonal 60 OMP #M# 60 antibody MAb 60 nanoviricides 60 cytotoxics 60 Monoclonal antibodies 60 prodrugs 60 glycosylation profile 60 synthetic peptides 60 antisense drugs 60 humanized antibodies 60 MEK inhibitors 59 antiviral therapeutics 59 anticoagulant reversing agent 59 mda 7 59 HuCAL antibody 59 ESBA# 59 selective orally bioavailable 59 antibody fragment 59 GAP #B# 59 OncoVEX 59 therapeutic mAbs 59 CDDO Im 59 Squalamine 59 JAK inhibitors 59 antisense inhibitors 59 preclinically 59 novel peptides 59 Azedra 59 PSMA ADC 59 GRNVAC1 59 immatics 59 Tarvacin 59 histone deacetylase inhibitor 59 glioblastoma multiforme GBM 59 adrenergic regulation 59 prophylactic vaccine 59 AEG# 59 immunological diseases 59 agonistic human 59 IgM antibodies 59 IAP inhibitors 59 DOS# 59 anti CD3 59 YONDELIS 59 Cytomegalovirus CMV 59 diagnostic assays 59 DCVax R 59 chimeric monoclonal antibody 59 investigational humanized monoclonal antibody 59 rxRNA 59 epithelial tumors 59 protein kinase inhibitor 59 immune modulating 59 monoclonal antibody therapies 59 Vaxfectin 59 ENMD # 59 transfection reagent 59 accumulate preferentially 59 adenoviral 59 oncolytic 59 engineered RAP peptides 59 cancer immunotherapies 59 IgG antibodies 59 Aplidin 59 anticancer compounds 59 NEUGENE antisense 59 CBLC# 59 androgen receptor antagonist 59 NEUGENE R 59 antithrombotic agents 59 oral antiviral 59 Litx 59 protein biochip 59 YONDELIS R 59 genetic biomarkers 59 multiplex assay 59 AFFiRiS 59 fusion proteins 59 HCV protease inhibitors 59 biotherapy 59 HAAH 59 druggable targets 59 Tesetaxel 59 rxRNA compounds 59 immunotherapeutic 59 assay detects 58 AAV vector 58 antibody 58 anti EGFR antibody 58 Aurora kinase inhibitor 58 novel immunotherapeutic 58 Solazed TM 58 lymphoid tumors 58 eTag assays 58 biologic pathway 58 humanized monoclonal 58 virotherapy 58 monoclonal antibody MAb 58 mGluR2 NAM 58 orally bioavailable mimics 58 ribonucleotide reductase clinically validated 58 oncology therapeutics 58 cleavable linker 58 myeloproliferative disorders 58 multitargeted 58 Viprovex TM 58 M2 subunit 58 ANG# 58 vinca alkaloids 58 DiLA2 58 peptidomimetic 58 oncolytic viruses 58 Antigenics QS 58 hemorrhagic fever viruses 58 chemically modified siRNA 58 oral prodrug 58 endogenous ligands 58 SinuNase ™ 58 virosome 58 Listeria vaccine 58 proliferative disorders 58 BiTE 58 Tarvacin Anti Viral 58 Phylomer ® 58 depsipeptide 58 humanized monoclonal antibody 58 naturally occurring antibodies 58 antisense oligonucleotides 58 CXCR4 receptor 58 co stimulatory molecules 58 PSMA antibody 58 biomarker assays 58 vinca alkaloid 58 Lodamin 58 synthetic retinoid 58 polyketides 58 carbohydrate antigens 58 HuLuc# 58 antiviral therapies 58 HCV polymerase inhibitors 58 AVI NEUGENE 58 erlotinib Tarceva ® 58 nucleoside analogs 58 DCVax 58 Alferon N 58 metabolite identification 58 ovarian prostate 58 allogeneic cell 58 XmAb# 58 resolvins 58 myelofibrosis polycythemia vera 58 nanobodies 58 RNA antagonist 58 microtubule inhibitor 58 antibodies 58 small molecule inhibitors 58 AMPK activators 58 PROLARIS 58 affinity antibodies 58 immunotoxin 58 immunomodulator 58 orally administered inhibitor 58 ErbB1 58 Radilex 58 aptamer 58 lipid nanoparticles 58 chimeric antibodies 58 neuroblastoma tumors 58 Locked Nucleic Acid LNA 58 siRNAs targeting 58 predictive toxicology 58 cancer immunotherapy 58 Intravenous Human 58 MT#/MEDI-# 58 gastro intestinal inflammation 58 huC# DM4 58 oral ghrelin agonist 58 inhibit metastasis 58 Zolinza 58 RNAi therapeutic 58 vaccines oncolytic virus 58 inhibit EGFR 58 NPM1 58 potent anticancer 58 ocular formulation 57 HTRF 57 multiplexed assays 57 PI3K/Akt pathway inhibitor 57 PI3K inhibitors 57 antiangiogenesis therapies 57 SynCon ™ DNA 57 THR beta agonist 57 DepoVax 57 ActA 57 cytotoxin 57 renin inhibitors 57 isoform selective 57 Tarmogen 57 HCD# [002] 57 molecular diagnostic assay 57 viral hemorrhagic fevers 57 JAK2 inhibitors 57 bispecific antibody 57 selective kinase inhibitor 57 FluCide 57 DermaVir 57 intranasal delivery 57 JAK3 57 bispecific antibodies 57 radiation sensitizer 57 PEG SN# 57 receptor tyrosine kinase inhibitor 57 FGFR 57 nanoviricide 57 NS#/#A protease 57 CCX# 57 selective antagonists 57 drug conjugate ADC 57 adenovirus vector 57 busulfan 57 humanised monoclonal antibody 57 BHT DNA 57 immunoconjugate 57 ovarian breast 57 molecularly targeted therapies 57 nonviral 57 hybridoma 57 IGF IR 57 candidate CRLX# 57 INS# [001] 57 acid phosphatase PAP 57 RiVax 57 multi kinase inhibitor 57 chimeric protein 57 #T# tumor 57 MAGE A3 ASCI 57 MVA BN R 57 ketolide antibiotic 57 Angiolix 57 Smac mimetics 57 radionuclide therapy 57 CEQ# 57 affinity ligands 57 Sym# 57 MEK inhibitor 57 biologic therapeutics 57 metastatic colorectal 57 splice variants 57 ALK inhibitors 57 Pertuzumab 57 recombinant subunit vaccine 57 MAb 57 selective kinase inhibitors 57 SERMs 57 CGEN # 57 nanoparticle formulation 57 proprietary BiTE ® 57 gastrointestinal stromal tumors GISTs 57 mAb 57 Quinamed 57 selective inhibitors 57 macrocycles 57 Virulizin ® 57 MKC# MT 57 fluoroquinolone antibiotic 57 drug GAP #B# 57 Biomerk Tumorgrafts 57 Homspera TM 57 Epidermal Growth Factor Receptor 57 attach auristatin 57 recombinant vaccines 57 IMC #B 57 PEGylated interferon 57 DNA plasmids 57 targeting CD# 57 NTDDS 57 MCSP respectively 57 MGd 57 Nasdaq IMGN biotechnology 57 TLR9 agonist 57 HepDirect prodrug 57 Fc fusion protein 57 bacterial biothreat agents 57 oncolytic virus therapies 57 bispecific 57 TLR8 57 lipopeptide 57 TTR gene 57 conserved sequences 57 HTS assay 57 P#X# 57 Nanobodies 57 using Crucell PER.C6 57 dasatinib Sprycel 57 Transdrug ® nanoparticle 57 CYT# novel 57 retaspimycin 57 miRview TM mets 57 novel therapeutic antibodies 57 Spiegelmers R 57 anti CD3 monoclonal 57 Ii protein 57 Tarvacin TM 57 Epstein Barr Virus EBV 57 delipidation 57 lipid nanoparticle 57 idiotype protein 57 HyperAcute 57 potent antiproliferative 57 transthyretin TTR 57 hematological cancers 57 bendamustine HCl 57 subunit vaccine 57 immune modulatory 57 Psoraxine R 57 ospemifene 57 MAbs targeting 57 KRAS oncogene 57 Stapled Peptide 57 FLT3 57 PCA3 gene 57 JAK2 inhibitor 57 botulinum neurotoxin 57 antibody arrays 57 BACcel 57 Provectus Pharmaceuticals specializes 57 protein microarrays 57 polymerase inhibitors 57 UniBody 57 ELISPOT assay 56 AKT inhibitor 56 siRNA compounds 56 Nanobodies R 56 anti CD# monoclonal 56 throughput RNAi 56 deacetylase inhibitors 56 small molecule modulators 56 HIV integrase inhibitors 56 TRAIL receptor antibodies 56 butyrylcholinesterase 56 siRNA knockdown 56 DXL# 56 shRNA libraries 56 transgenic mouse models 56 interferon lambda 56 antisense inhibitor 56 MTP inhibitor 56 rituximab Rituxan 56 BGC# 56 investigational monoclonal antibody 56 Aptamer 56 Sphingomab 56 Dendritic cell 56 anti infective treatments 56 rxRNA ™ compounds 56 XmAb 56 hereditary emphysema 56 telomerase inhibitor 56 tumor specific antigen 56 therapeutic peptide 56 OncoVEX GM CSF 56 protein antigens 56 epigenetic therapeutics 56 vitro assay 56 NSCLC tumors 56 chemotherapeutic drug 56 glycolipids 56 influenza subtypes 56 biologic therapies 56 telomerase therapeutic 56 HSP# inhibitor 56 immunotherapeutic agent 56 subunit vaccines 56 imatinib Gleevec 56 EndoTAG TM 56 ActivX 56 Radiation Therapy SIRT 56 Multimeric 56 adenovector 56 orphan GPCRs 56 mouse xenograft models 56 oral JAK1 56 anionic backbone 56 investigational compounds 56 drug conjugates ADCs 56 immunoregulation 56 varicella zoster virus VZV 56 malaria parasite genome 56 isotypes 56 viral antigens 56 candidates Azedra TM 56 Monoclonal 56 Fludara ® 56 attenuated strain 56 liposomal delivery 56 Crizotinib 56 phage display 56 hormone gastrin 56 mimetic compounds 56 immunotherapeutic vaccine 56 carcinoid 56 L. pneumophila 56 orally bioavailable 56 tkRNAi technology 56 proteomic analysis 56 anticancer compound 56 FluChip 56 Alfacell proprietary ribonuclease 56 Combivir Kivexa 56 lentiviral vectors 56 neuropsychiatric diseases 56 previously undescribed 56 antitumoral 56 RhuDex ® 56 trastuzumab DM1 T DM1 56 immunotoxins 56 OHR/AVR# 56 echinocandins 56 oncolytic virus 56 liposomal doxorubicin 56 silico prediction 56 Molecular imaging 56 PORxin 56 EndoTAG 56 bortezomib Velcade 56 CCR9 antagonist 56 liposome formulations 56 nanocarriers 56 ALN TTR# 56 vaccine GRNVAC1 56 Adnectin 56 enzyme inhibitor 56 prostone 56 menstrual stem cell 56 EHT AGN 56 therapeutics 56 POTELLIGENT ® 56 recombinant fusion 56 RayBiotech 56 cytostatic 56 hA# 56 AAG geldanamycin analog 56 siRNA therapeutics 56 RAV# 56 IgG1 monoclonal antibody 56 BRAF inhibitor 56 IgM antibody 56 vivo validation 56 LEAPS TM 56 ADAMTS# 56 novel antiviral therapeutics 56 ALN TTR 56 selective inhibition 56 flavopiridol 56 Endotoxin Activity Assay 56 microRNA biomarkers 56 HCV protease inhibitor 56 drugable targets 56 OnDose TM 56 Vidofludimus 56 Enzastaurin 56 influenza VLP vaccines 56 Ceflatonin 56 serine protease 56 nucleotide analogs 56 PORxin TM 56 serum antibodies 56 pediatric acute lymphoblastic 56 therapeutic antibody 56 AdVac ® 56 synthetic siRNA 56 GelSite polymer 56 NY ESO 56 TLR agonists 56 PARP inhibitors 56 histone deacetylase inhibitors 56 HER2 ErbB2 56 isotype 56 anticancer therapies 56 humanised antibody 56 Gleevec resistant 56 BAL# [001] 56 nucleoside analogues 56 CD# CEA 56 TÎ ² 4 56 retroviral vectors 56 TH# cells 56 AvalonRx R 56 immunotherapeutic approaches 56 Safinamide 56 camptothecin 56 Immunotherapeutic 56 antagomirs 56 Cylene 56 TELCYTA TM TLK# 56 ArQule Kinase Inhibitor Platform 56 thymalfasin 56 replicon 56 HuMax EGFr 56 optical biosensors 56 N glycan 55 DGAT 55 small molecule defensin 55 potent inhibitors 55 antimicrobial compounds 55 miRview mets 55 fusion enhancers 55 CR# vcMMAE 55 Onalta 55 small molecule agonists 55 kinase inhibition 55 immune modulator 55 Oncotype DX colon cancer 55 engineered proteases 55 photosensitizer 55 Deforolimus 55 SynCon TM 55 herpes simplex viruses 55 TTR amyloidosis 55 transgenic rats 55 PARP inhibition 55 Basal cell 55 inhibit viral replication 55 Medarex UltiMAb R 55 outer membrane proteins 55 MVA BN 55 Receptos 55 diagnostic prognostic 55 Sphingomab TM 55 alvespimycin 55 HDACi 55 molecular assays 55 Enkephalin 55 pan HDAC inhibitor 55 enzyme inhibitors 55 pDNA vaccines 55 telomerase activators 55 superantigens 55 therapeutic radiopharmaceuticals 55 xenograft models 55 apoptotic pathway 55 selective immunoproteasome inhibitor 55 genomic biomarker 55 Panzem 55 DepoVax TM 55 recombinant adeno associated 55 PROSTVAC TM 55 romazarit 55 oral Janus kinase 55 filoviruses 55 Cyclin E 55 Regado 55 Affimed Therapeutics AG 55 SCIB1 55 pancreatic enzyme replacement 55 LentiVector technology 55 cyclophilin inhibitors 55 microRNA miRNA 55 psoriasis rheumatoid arthritis 55 HSP# inhibitors 55 catalytic antioxidant compounds 55 Epratuzumab 55 PDGF receptor 55 candidate deforolimus 55 lentiviral vector 55 adult mesenchymal stem 55 prolyl hydroxylase inhibitors 55 peptide ligands 55 commercialize deforolimus 55 AGS PSCA 55 miRNA therapeutics 55 VEGF receptor 55 novel VDA molecule 55 protein tyrosine phosphatase 1B 55 colorectal bladder 55 DermaVir Patch 55 Micromet proprietary BiTE 55 sPLA2 55 antiproliferative effects 55 histone deacetylase HDAC inhibitors 55 TRAIL receptor 55 anti CD# antibody 55 anti angiogenic drugs 55 Kevetrin ™ 55 Xanafide 55 Western Blotting 55 anti angiogenic agent 55 Trofile assay 55 Carigent 55 Aurora kinase 55 Aeolus Pharmaceuticals 55 nanocarrier 55 LHRH antagonists 55 Scancell 55 antisense drug 55 Guanilib 55 effector function 55 PI3K Akt 55 Neugene 55 PRLX # 55 immunized mice 55 DepoVax ™ 55 CD# expressing 55 Smac mimetic 55 viral proteins 55 antibody reagents 55 diagnostic biomarkers 55 K ras mutations 55 theranostic 55 Transfection Reagent 55 trial evaluating PRX# 55 antibacterial compounds 55 neuraminidase inhibitor 55 5 HT2A serotonin 55 GBM tumors 55 immunodeficiency disorders 55 optimal dosing regimens 55 BiTE antibody 55 Anticalins ® 55 CTLA4 Ig 55 XL# inhibits 55 alpha interferon 55 KNS # 55 RECOTHROM R 55 XmAb ® 55 MUC1 protein 55 OXIGON TM 55 molecular determinants 55 cathepsins 55 indibulin 55 INxin TM 55 biochemical assays 55 RhuDex R 55 Zysolin TM 55 bioscavenger 55 DXL ™ 55 LungExpress Dx 55 GeneICE 55 Hemopurifier 55 NB S# strontium malonate 55 PKC enzyme 55 Carfilzomib 55 antigen sparing 55 proteins peptides 55 NP2 55 Cathepsin S 55 virus AAV 55 ophthalmic therapeutics 55 CCR1 55 p# antigen 55 targeted immunotherapies 55 IAP inhibitor 55 HepDirect R 55 Thiovir 55 iRGD 55 Anavex #-# 55 targeted anticancer therapeutics 55 PORxin TM platforms 55 hematological indications 55 pharmacogenetic test 55 colon pancreatic 55 investigational pan BCR 55 oncolytic virus therapy 55 ALN VSP 55 histone deacetylase HDAC inhibitor 55 markets biosurgical 55 Kahalalide F 55 GRN# 55 epothilone 55 UltiMAb 55 anti CTLA 55 MORAb 55 IMPDH 55 miRNA molecules 55 monoclonals 55 AKT1 55 Factor VIIa 55 Leukine ® 55 nanomolar 55 NS5b 55 Omacetaxine 55 CD# monoclonal antibody 55 small molecule activators 55 p# inhibitors 55 tumor subtypes 55 Aflibercept 55 selective modulator 55 metabolite profiling 55 immunogens 55 investigational therapies 55 systemic RNA interference 55 GV# [001] 55 GeoVax vaccine 55 radiolabeled antibodies 55 glycan 55 bioactive lipids 55 peptide conjugated 55 short hairpin RNAs 55 p# biomarker 55 Myolimus 55 Trofex TM 55 QPCR 55 nanoviricide drug 55 5 HT4 receptor 55 Phase #b/#a clinical 55 JAK1 55 mGluR4 55 Allovectin 7 55 antibody binds 55 Charlesson 55 LEX System 55 prostate cancer antigen prostatic 55 Symadex 55 BRAF inhibitors 55 Septin9 biomarker 55 MyVax R 55 CompoZr 55 Epeius Biotechnologies Corporation 55 SynCon TM DNA 55 commercializing anti infective 55 TPI ASM8 55 missense mutations 55 auristatin 55 IgE antibody 55 HepaLife 55 Human cl 55 chronic viral infections 55 Mersana Therapeutics 55 liposomal formulation 55 Myocet 55 CD# antibody [001] 55 antisera 55 multi analyte 55 reverse vaccinology 54 covalent drugs 54 Zemiva TM 54 BC SeraPro ™ 54 nCounter Analysis System 54 selective agonist 54 Th2 cytokines 54 ImmunoVEX HSV2 54 Septin 9 54 vivo efficacy 54 antiangiogenesis 54 delafloxacin 54 OxBC 54 agonist compounds 54 chemical entities NCEs 54 Janus Kinase 54 thymosin beta 4 54 HuCNS SC ® 54 essential thrombocythemia ET 54 Calando proprietary 54 biodegradable nanoparticles 54 aTyr Pharma 54 ALDH br cells 54 Pancreate 54 Temsirolimus 54 proprietary LNA 54 preclinical compounds 54 GelSite R polymer 54 zinc finger nuclease 54 IgG1 54 alpha folate receptor 54 glutamic acid decarboxylase 54 Genentech Rituxan 54 dependent cellular cytotoxicity 54 Affymetrix microarray technology 54 antifungal agent 54 synergistic combinations 54 lipidoid 54 p# inhibitor 54 Septin9 54 Cardiotoxicity 54 antisense compounds 54 antitumor 54 PROfusion 54 Scil Proteins 54 ProMune 54 molecular radiotherapeutics 54 transcriptome sequencing 54 validating biomarkers 54 immuno modulatory 54 selective estrogen receptor modulator 54 Campath ® 54 HCV polymerase 54 anti amnesic 54 epigenetic enzymes 54 Interferons 54 adenovirus vectors 54 proprietary biomaterials 54 TLR antagonists 54 lexidronam injection 54 inhibit angiogenesis 54 calcium phosphate nanoparticles 54 ALN PCS 54 VZV 54 antiangiogenic agents 54 lymphoid cells 54 drug conjugate 54 benign neoplasms 54 Anticalin ® 54 Corus CAD 54 preanalytical solutions 54 epothilones 54 BioMAP ® Systems 54 chemokine receptor 54 multiplex assays 54 H#N# VLP vaccine 54 antisense inhibition 54 nitric oxide donating 54 splice variant 54 mimetics 54 Peptidomics 54 IMiDs R 54 immune modulators 54 potent inhibitory 54 Dyax phage display 54 CCR9 54 preclinical efficacy 54 Epothilones 54 cancer therapeutics 54 novel immunomodulatory 54 resolvin 54 HER1 54 HuCAL R 54 midkine 54 adenoviral vectors 54 MDSCs 54 enhance ApoA 54 imatinib Gleevec ® 54 Talabostat 54 systemic RNAi therapeutic 54 colon carcinoma 54 Factor Receptor 54 Dicer Substrate Technology 54 multigene expression test 54 PDE# inhibitors 54 cytoprotective 54 Lpathomab 54 Janus kinase 54 photodisinfection 54 pandemic influenza strains 54 Onalta ™ 54 anti mitotic 54 metaglidasen 54 GPx 54 biased ligand 54 prognostic biomarkers 54 Seliciclib 54 LNP formulations 54 Chemokine Receptor 54 pharmacodynamic biomarkers 54 P#X# antagonist 54 chimeric antibody 54 hybridomas 54 HER2 overexpression 54 TG# [003] 54 PROCHYMAL 54 monoclonal anti 54 methylated DNA 54 HCV antiviral 54 Marburg viruses 54 miRview ™ mets 54 tiapamil 54 beta lactamases 54 pathophysiological effects 54 immunomodulatory properties 54 TNFa 54 Micromet BiTE 54 ANTISENILIN ® 54 pDCs 54 brostallicin 54 autologous cellular immunotherapy 54 NeuroTrans TM 54 Therapeutic antibodies 54 SynCon 54 viral pathogens 54 Oral NKTR 54 ELISA kit 54 T SPOT.TB 54 glycopeptides 54 viral genomes 54 Vicinium TM 54 Aviptadil 54 humanized anti 54 HER2/neu 54 eIF 4E 54 Angiocept 54 Belimumab 54 Fibroblast Growth Factor Receptor 54 plasmid DNA vaccine 54 oxazolidinone 54 sigma receptors 54 neoplastic diseases 54 Onco TCS 54 rabbit polyclonal 54 NF kB pathway 54 GRNOPC1 contains 54 RNA therapeutics